Robust cytotoxic CD8
+ T-cell response is important for immunity to intracellular pathogens. Here, we show that the transcription factor IFN Regulatory Factor 4 (IRF4) is crucial for the protective CD8 
CD8
+ T cells showed impaired memory-cell formation, indicating additional functions for IRF4 in this process. As IRF4 governs B-cell and CD4
+ T-cell differentiation, the identification of its decisive role in peripheral CD8 + T-cell differentiation, suggests a common regulatory function for IRF4 in adaptive lymphocytes fate decision.
F ollowing infection with intracellular pathogens, specific CD8 + T cells become activated, proliferate, and differentiate into cytotoxic T cells, which are critical for the clearance of infection. Upon antigen encounter, these effector cells produce inflammatory cytokines and have the capability to kill infected cells. After resolution of infection, the bulk of effector cells dies; however, a small fraction remains as long-lived memory T cells that respond with rapid conversion into effector cells upon reexposure to the cognate pathogen (1) .
Phenotypic and functional markers allow distinction between short-lived effector CD8
+ T cells and cells that give rise to longlived memory cells already at early stages of the response. Ef (1) . Differentiation of CD8 + T cells into effector and memory cells is regulated by balanced expression of several transcription factors (TF). Whereas BCL-6 (2, 3), Eomesodermin (Eomes) (4), Id3 (5, 6) , and TCF-1 (7) are associated with memory cell differentiation and longevity of cells, T-bet (encoded by Tbx21) (4, 8) , Id2 (9) , and Blimp-1 (encoded by Prdm1) (10, 11) promote effector cell development.
The transcription factor IFN regulatory factor 4 (IRF4) controls class-switch recombination, germinal center B-cell formation, and plasma cell development (12) . In CD4 + T cells, IRF4 is crucial for the differentiation into T helper (Th) subsets such as Th2, Th9, Th17, and Tfh cells (13) (14) (15) (16) (17) (18) . Mechanistically, IRF4 controls B-cell and dendritic cell differentiation by cooperative DNA binding with TFs of the Ets family on Ets-IRF composite elements (EICE) as well as by cooperation with basic leucine zipper transcription factor ATF-like (BATF)-JUN heterodimers in binding to AP-1-IRF4 composite elements (AICE) (19) (20) (21) (22) (23) . In contrast, differentiation of CD4 + T cells relies mainly on IRF4 binding to AICE elements (19, 21, 22) . Moreover, there is evidence for cooperation of IRF4 with other TFs, including members of the NFAT, STAT, or homeobox protein families (12) .
There is only limited information on the function of IRF4 in CD8 + T cells. IRF4-deficient (Irf4 −/− ) mice are impaired in their response to lymphocytic choriomeningitis virus infection (24) and IRF4 appears to control expression of Eomes in these cells (25, 26) . Here, we investigate the role of IRF4 in CD8 + T cells during an immune response against the intracellular bacterium Listeria monocytogenes and demonstrate an intrinsic role for IRF4 in the differentiation of peripheral cytotoxic T lymphocytes.
Results

IRF4
Is Essential for Clearance of L. monocytogenes. Infection of mice with L. monocytogenes induces a robust effector CD8 + T-cell response, which is crucial for clearance of bacteria (27) . To elucidate the role of IRF4 in generation of protective CD8
−/− and WT mice were infected with L. monocytogenes.
Compared with WT mice, Irf4
−/− mice were compromised in the eradication of L. monocytogenes (Fig. 1A and Fig. S1A ). Furthermore, the expansion of the CD8 + T-cell population and the acquisition of the CD62L Mice. To characterize the function of IRF4 in an antigen-specific setting, WT and Irf4 −/− mice were infected with an L. monocytogenes strain recombinant for chicken ovalbumin (LmOVA).
Irf4
−/− mice also failed to clear the LmOVA infection (Fig. S2A ). We noted a significant reduction in OVA-specific CD8 + T cells in tissues of Irf4 −/− mice and these cells failed to acquire a CD62L lo KLRG1 hi phenotype ( Fig. 2 A-C) . OVA-specific cytokine production was also greatly impaired in Irf4 −/− mice compared with WT mice (Fig. 2D) . Infection with an L. monocytogenes strain recombinant for gp33 from LCMV revealed a comparable defect (Fig. S2 B-E) . Furthermore, we failed to detect substantial responses to H2-M3-restricted formyl-methionin (f-met) peptides of L. monocytogenes (Fig. S2 B and C) . Thus, Irf4 −/− mice fail to mount a regular CD8 + effector response to several immunodominant peptides presented by different MHC molecules during infection with L. monocytogenes.
−/− CD8 + T Cells Display Altered Proliferative Behavior. The analysis of L. monocytogenes clearance suggested an intrinsic defect of CD8 + T cells in Irf4 −/− mice ( Fig. 1 B and C) . To fully isolate the IRF4 deficiency to CD8 + T cells, we conducted competitive transfers of small numbers of both WT and Irf4 −/− OVA-specific OT-I CD8 + T cells into congenic WT recipients, followed by LmOVA infection. At day 3 after transfer and infection, we found similar numbers of WT and Irf4 −/− OT-I cells in spleens of recipient mice; however, at day 5 the ratio changed to approximately 10:1 ( Fig. 3 A and B and Fig. S3 A and B) .
Reduced accumulation of Irf4
−/− OT-I cells was also found in other tissues (Fig. S3C) , and noncompetitive T-cell transfers gave similar results ( Fig. S4 A and B) . Phenotypically, transferred Irf4 −/− OT-I cells displayed less pronounced up-regulation of CD44, CXCR3, and CD25, suggesting that they reacted to LmOVA, although to a lesser extent than WT cells. Furthermore, they failed to down-regulate CD62L and CD27 and to up-regulate KLRG1, again confirming that phenotypic alterations of CD8 + T cells observed in Irf4 −/− mice were due to an intrinsic defect of these cells (Fig. 3C and Fig. S3 D and G) . Consistently, IRF4 was rapidly induced by polyclonal or antigen-specific stimulation and during L. monocytogenes infection, its induction correlated with the acquisition of the effector phenotype by CD8 + T cells (Fig. S5 A-F) .
To elucidate whether reduced accumulation of Irf4 −/− CD8 + T cells was caused by restricted proliferation, we measured carboxyfluorescein succinimidyl ester (CFSE) dilution. Both WT and Irf4 −/− OT-I cells had proliferated extensively as measured at day 5 posttransfer (Fig. 3D) . Because impaired accumulation of Irf4 −/− OT-I cells was evident at day 5 but not at day 3 posttransfer and infection, we speculated that Irf4 −/− CD8 + T cells might not maintain an initial proliferation. Indeed, BrdU incorporation by Irf4 −/− cells between days 4 and 5 was significantly lower, compared with that by WT cells (Fig. 3E) , suggesting reduced proliferation of Irf4 −/− cells at this stage of infection. The proliferative defect of Irf4 −/− cells was also detectable in vitro and could not be rescued by the addition of high amounts of IL-2 (250 units) ( Fig. S6 A and B) . The rate of apoptosis was reduced in Irf4 −/− OT-I cells at day 5 p.i. as determined by fluorescent labeled inhibitor of caspases (FLICA) and Annexin V staining, and Irf4
−/− cells expressed higher levels of the prosurvival factor Bcl2 ( Fig. 3F and Fig. S3 E and F), reflecting again their defect to mature into effector cells that are more prone to apoptosis (28) . Furthermore, the expression of the exhaustion markers CD244, LAG-3, and PD-1 (29) −/− cells already displayed impaired IFN-γ, TNF-α, and GzmB production at this time point and the defect in GzmB expression was even more pronounced at day 5 ( Fig. 4 A, B , and D and Fig. S7 A and B) . Irf4
−/− cells also failed to produce IL-2 (Fig. 4C) . The defect of Irf4 −/− cells in production of IFN-γ and TNF-α was also detectable in vitro and could not be rescued by addition of high amounts of IL-2 (Fig. S6C) . The mRNA analysis of sorted WT and Irf4 −/− OT-I cells isolated from acute infection revealed decreased levels for the cytotoxic molecules GzmB, Granzyme K, and Perforin 1 (Fig. 4E) . Consistent with this result, we detected impaired cytotoxicity of Irf4 −/− OT-I cells in an in vivo kill assay after transfer of LmOVA-activated WT and Irf4 −/− OT-I cells (Fig. 4F) . Importantly, diminished cytotoxicity was not caused by loss of Irf4 −/− OT-I cells because we detected similar numbers of transferred cells in recipients of WT and Irf4 −/− cells (Fig. 4F ). In summary, these results demonstrate an intrinsic defect of Irf4 −/− CD8 + T cells to acquire functions of terminal effector cells during L. monocytogenes infection.
To exclude developmental defects of Irf4 −/− CD8 + T cells, we retrovirally overexpressed IRF4 in LmOVA-primed WT or Irf4
OT-I cells (7, 8) . Cells were transferred into congenic mice, which were infected with LmOVA (Fig. 4 G and H) . WT cells transduced with control virus (control-RV) or IRF4-expressing virus (IRF4-RV) displayed similar production of IFN-γ and TNF-α. Irf4 T cells rescued at least partially the cytokine production, corroborating the crucial role of IRF4 for CD8 + effector differentiation and excluding developmental defects.
IRF4 Controls Expression of Transcription Factors Regulating CD8
+ T-Cell Fate Decision. Differentiation of effector CD8 + T cells is controlled by coordinated expression of several TFs (2-11). Therefore, WT and Irf4 −/− OT-I CD8 + T cells were sorted from recipient mice during acute L. monocytogenes infection and mRNA levels for different TFs were determined by quantitative RT-PCR analysis (Fig. 5) . Consistent with severely impaired effector differentiation of Irf4 −/− CD8 + T cells, we found diminished expression of TFs important for CD8
+ effector-cell development such as Prdm1 (encoding Blimp-1), Id2, and Tbx21 (encoding T-bet) in these cells. Notably, the expression of TFs associated with memory T-cell differentiation such as BCL-6, Eomes, and Id3 was increased in Irf4 −/− CD8 + T cells. This feature combined with the CD44 hi CD62L hi memory-like phenotype of activated Irf4 −/− CD8 + T cells ( Fig. S1D and Fig. 3C ) suggested that absence of IRF4 might promote the formation of memory CD8
+ T cells. However, in two experimental approaches in which either CD8 + T cells were directly analyzed in Irf4 −/− mice or Irf4 −/− OT-I cells were analyzed after transfer into WT recipients, we noted decreased numbers of OVA-specific CD8 + T cells 40 d after LmOVA infection and these cells were profoundly impaired in IFN-γ and TNF-α production after stimulation (Fig. S8 A-H) . Thus, the formation as well as the function of long-lived memory CD8
+ T cells was markedly impaired in the absence of IRF4.
IRF4 Binds Directly to Regulatory Elements of the Prdm1 Gene in CD8
+ T Cells. Blimp-1-deficient CD8 + T cells display impaired cytotoxicity and express diminished levels of KLRG1 and Tbx21, whereas the expression of Eomes and Bcl6 is increased in these cells. Therefore, Blimp-1 has been defined as a central TF for terminal effector CD8 + T-cell differentiation (10, 11) . Because of similarities in the phenotype of Irf4 −/− CD8 + T cells and that described for Blimp-1-deficient CD8 + T cells and strong reduction of Prdm1 expression in Irf4 −/− CD8 + T cells during acute L. monocytogenes infection, we hypothesized that IRF4 regulates Prdm1. To test this, CD8 + T cells from WT and Irf4 −/− mice were activated in vitro and then cultured with cytokines contributing to CD8 + T-cell activation (Fig. 6A ). Without addition of cytokines, Irf4
−/− CD8 + T cells showed reduced expression of Prdm1 compared with WT cells. IL-2 even in high concentrations and IL-12 did not change the expression level of Prdm1 in both populations (Fig. 6A and Fig. S6D ). Consistent with published data for CD4 + T cells (30) , IL-21 strongly induced Prdm1 and Blimp-1 protein in WT CD8 + T cells, which corresponded to enhanced IRF4 levels. In agreement with our ex vivo data, Prdm1 expression was markedly lower in Irf4 −/− cells and Blimp-1 was undetectable (Fig. 6 A-C) . Reduced expression was not due to a failure of Irf4 −/− CD8 + T cells to react to IL-21, because WT and Irf4 −/− cells displayed similar phosphorylation of STAT3 upon IL-21 treatment (Fig. S9A) . Furthermore, the transduction of Irf4 sites, for two of which we found specific binding (Fig. 6E) . Precipitation with anti-IRF4 Ab resulted in significant enrichment of the analyzed regulatory elements of Prdm1 compared with precipitation with control IgG and there was no significant binding of IRF4 to control sequences from the 5′ region of the Rpl32 gene, which does not contain canonical IRF motifs (Fig. S9C ). These results demonstrate that in CD8 + T cells, IRF4 is essential for Blimp-1 expression and binds specifically to regulatory regions of the Prdm1 gene and suggest that the regulation of Blimp-1 by IRF4 contributes to the impaired effector differentiation of Irf4 (31) . Our data extend these observations to CD8
+ T cells and suggest the IRF4-Blimp-1 axis as a common regulatory mechanism in lymphocytes.
Because Blimp-1 controls terminal effector differentiation and the expression of other TFs involved in lymphocyte differentiation such as T-bet, Eomes, BCL-6, and Id3 (10, 11) , impaired induction of Blimp-1 in the absence of IRF4 could be largely responsible for the defective effector differentiation of Irf4 epigenetic remodeling and energy metabolism (32) . It is possible that BATF and IRF4 cooperatively affect CD8 + T-cell effector differentiation either by regulation of effector proteins and TFs or by promoting changes in metabolic pathways. In B cells and CD4 + T cells, IRF4 additionally cooperates with several other TFs, including members of the ETS family, E47, NFATc2, STAT3, and STAT6 (12) . In CD8 + T cells IRF4 might interact with some of these molecules as well to influence differentiation.
Analysis of TFs in Irf4 −/− CD8 + T cells revealed up-regulation of BCL-6, Eomes, and Id3. We and others have recently described high Eomes expression in Irf4 −/− CD8 + T cells (25, 26) . High expression of BCL-6, Eomes and Id3 and low expression of Blimp-1, Id2, and T-bet are associated with the development of memory CD8 + T cells (1) . However, only marginal numbers of LmOVA-specific CD8 + T cells were detectable in Irf4 −/− mice and they mostly failed to produce cytokines upon stimulation. Thus, IRF4 controls maturation processes essential for the generation of both effector and memory CD8 + T cells. The rapid induction of IRF4 after T-cell activation suggests that IRF4 acts already at early differentiation steps that are common to both fates. Along with this model, IRF4 may function as a permissive factor by rendering precursor-like cells responsive to fate-shaping environmental cues such as cytokines, costimulatory signals, or different antigen loads that are encountered in the course of infection. Consequently, loss of IRF4 causes a disbalanced transcriptional program that immediately affects effector-cell generation during acute infection but also prevents the formation of functional memory CD8 + T cells. In conclusion, our results identify IRF4 as a central regulator of peripheral CD8 + T-cell differentiation. These data parallel observations in late stages of B-cell development (12) and in generation of Th-cell subsets (13) (14) (15) (16) (17) (18) and thus support the idea of conserved transcriptional modules regulating peripheral differentiation of adaptive lymphocytes (33) . Isolation of Cells and Flow Cytometry. Lymphocytes were isolated from different tissues as previously described (36) . For extracellular staining, cells were incubated with rat serum and anti-CD16/CD32 mAb and then stained with specific mAb as indicated. Ovalbumin-specific CD8 + T cells were Values for nonspecific binding (as determined by using control IgG) were subtracted; nd, not detectable. Shown is mean ± SEM of combined results from three independent experiments (n = 9); ns, not significant. prepared using the RNeasy Micro Kit (Qiagen). cDNA synthesis and PCR were performed as described previously (37) . mRNA expression levels were normalized to hypoxanthine-guanine phosphoribosyl transferase (Hprt1) expression and relative fold differences were calculated. The lowest experimental value was set to 1. The primer sets have been described previously (37) . The primer pair for Bcl6 detection was forward, 5′-CCTGTGAAATCTGTGGCACTCG-3′, and reverse, 5′-CGCAGTTGGCTTTTGTGACG-3′.
Immunoblotting. Whole-cell lysates were prepared from purified CD8 + T cells without stimulation or after in vitro stimulation. Immunoblotting was performed, as described previously (26) . Briefly, proteins were fractionated by SDS/ PAGE, transferred to nitrocellulose membrane, immunoblotted with pSTAT3 Tyr705 (9131; Cell Signaling Technology), IRF4 (M-17; sc6059; Santa Cruz) or Blimp-1 (Novus) antibodies, and then reprobed with antibodies to total STAT3 (124H6; 9139; Cell Signaling Technology) or β-Actin (Sigma-Aldrich).
Chromatin Immunoprecipitation Assays. For ChIP experiments, CD8 + T cells enriched by negative MACS selection were preactivated with plate-bound anti-CD3 mAb (2 μg/mL) and soluble anti-CD28 mAb (1 μg/mL) in the presence of rhIL-2 (50 units/mL) for 3 d, rested overnight, and stimulated with IL-21 (100 ng/mL) for 1 h. A total of 2 × 10 6 cells were fixed with 1% formaldehyde for 10 min at room temperature to preserve the protein-DNA interactions. Subsequently, ChIP was performed as described previously (38) with antibodies against IRF4 (M-17; Santa Cruz). Quantitative RT-PCR with the precipitated chromatin was performed to calculate the percentage of input. Primer sequences are provided in Table S1 . All amplifications were performed in triplicate with SYBR Green PCR Master Mix (Qiagen). Control ChIP was performed with a respective isotype control antibody to ensure specificity. After normalization of the data according to the isotype control, the specific pulldown (percentage of input chromatin) was calculated.
In Vivo Cytotoxicity Assay. Statistics. All described experiments were performed at least two times with similar results. For statistical analysis of frequencies and cell numbers, we applied an unpaired two-tailed Student's t test. Bacterial titers were compared using the Mann-Whitney test. P values are indicated as follows: *P < 0.05; **P < 0.01; ***P < 0.001. Additional methods can be found in SI Material and Methods.
